Luis Gomez, MD
Colon & Rectal Surgery · El Paso, TXNPI 1881647659
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Endologix LLC at 56.4% of the total. Reporting peaked in 2023 at $3,506 and has fallen 97.4% since, to $90 in 2025.
Across 53 payments — averaging $115.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$3K
- W. L. Gore & Associates, Inc.$2K
- Kerecis Limited$125
- Cook Medical LLC$119
- GSK$68
- TELA Bio, Inc.$67
- plus $142 from 6 others
What the payments were for
- Consulting fees$3,45056%
- Travel & lodging$91215%
- Food & beverage$1,75329%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 3 | $3,450 |
| W. L. Gore & Associates, Inc. | 33 | $2,143 |
| Kerecis Limited | 3 | $125 |
| Cook Medical LLC | 1 | $119 |
| GSK | 4 | $68 |
| TELA Bio, Inc. | 1 | $67 |
| Bard Peripheral Vascular, Inc. | 1 | $43 |
| Medtronic | 3 | $39 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Davol Inc. | 1 | $17 |
| Merck | 1 | $11 |
| Bolder Surgical LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,115 in reported general payments places this provider in the 55th percentile of 200 colon & rectal surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Procto-Med HcHydrocortisone | 24 | $1,036 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 40 | $1,009 |
| Cholestyramine LightCholestyramine | 15 | $977 |
| Hydrocortisone | 40 | $918 |
| Ondansetron OdtOndansetron | 79 | $723 |
| Neomycin Sulfate | 85 | $540 |
| SsdSilver Sulfadiazine | 14 | $367 |
| Metronidazole | 92 | $358 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $240 |
| Tamsulosin Hcl | 17 | $134 |
| Tramadol Hcl | 36 | $82 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in El Paso
- Thiru LakshmanAustin$756K
- Diego Marines CopadoHouston$462K
- Bidhan DasSugar Land$350K
- Christopher de JesusSan Antonio$201K
- Farshid AraghizadehFort Worth$181K
- Jefferson HurleyIrving$163K
- Erik AskenasyHouston$142K
- Eric HaasHouston$140K
- Robert JacobsonDallas$125K
- Theodoros VoloyiannisHouston$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.